How to Reduce Albumin in Urine: Causes of Proteinuria and Steps to Lower It

Quick answer: Albumin in the urine (albuminuria) indicates that the kidney's filtration barrier is allowing protein to pass that should normally be retained in the bloodstream. Common causes include high blood pressure, diabetes and insulin resistance, chronic kidney disease, and high dietary sodium intake. A urine albumin-to-creatinine ratio (UACR) is the standard measure. Factors consistently associated with lower albuminuria include blood pressure management, blood glucose control, dietary sodium reduction, and in some cases renin-angiotensin system medications under provider supervision.

What it Means When Albumin Appears in Urine

The kidneys filter roughly 180 liters of blood per day, retaining useful proteins and excreting waste. Albumin, the most abundant protein in blood, is ordinarily too large to pass through the glomerular filtration membrane into the urine in significant amounts. When albumin is detected in urine above trace levels, it signals that the glomerular barrier is compromised — either structurally, through elevated intraglomerular pressure, or through inflammatory and metabolic damage to the filtration membrane.

The clinical significance depends on the amount. Microalbuminuria (now more precisely called moderately increased albuminuria) refers to urinary albumin excretion of 30–300 mg per day or a urine albumin-to-creatinine ratio (UACR) of 30–300 mg/g. Macroalbuminuria (severely increased albuminuria) is UACR above 300 mg/g. Even persistent low-level albuminuria in the microalbuminuria range is an established early marker of kidney injury and is independently associated with cardiovascular risk.

What Causes Albumin to Appear in Urine

High blood pressure (hypertension)

Sustained elevated blood pressure transmits excess hemodynamic stress to the glomerular capillaries. Over time, this pressure-related injury damages the filtration membrane and promotes glomerulosclerosis (scarring of the glomeruli). The kidney is highly sensitive to blood pressure changes, and even systolic pressures in the 130s (now classified as stage 1 hypertension by ACC/AHA criteria) are associated with increased albuminuria risk. Effective blood pressure management is one of the most consistently evidence-supported strategies for reducing albuminuria — both pharmacologically and through lifestyle-based approaches including sodium restriction, the DASH dietary pattern, and weight management.

Diabetes and high blood sugar

Diabetic nephropathy is the leading cause of chronic kidney disease in high-income countries. Elevated blood glucose damages glomerular endothelial cells, podocytes (the filtration membrane's structural cells), and mesangial tissue through multiple mechanisms including advanced glycation end-product (AGE) accumulation, oxidative stress, and activation of inflammatory pathways. Albuminuria is one of the earliest clinical indicators of diabetic kidney involvement, appearing years before GFR decline. In individuals with type 2 diabetes, a UACR above 30 mg/g warrants clinical attention even in the absence of other kidney function abnormalities.

Maintaining blood glucose within the target range established with a provider — reflected through HbA1c and fasting glucose monitoring — is associated with reduced albuminuria progression in diabetes.

Insulin resistance and metabolic syndrome

Albuminuria is associated with insulin resistance independent of diabetes diagnosis. Hyperinsulinemia and insulin signaling impairment promote endothelial dysfunction and may impair the selective permeability of the glomerular filtration barrier. Metabolic syndrome — characterized by visceral adiposity, elevated triglycerides, low HDL, elevated blood pressure, and impaired fasting glucose — is associated with increased albuminuria even in the absence of frank type 2 diabetes. Addressing the components of metabolic syndrome (through dietary quality, weight management, and physical activity) is associated with improvement in renal markers.

Dietary sodium intake

High sodium intake raises blood pressure and promotes intraglomerular hypertension independent of systemic blood pressure effects, through the renin-angiotensin-aldosterone system. Research has found that higher habitual sodium intake is associated with greater albuminuria, and reducing dietary sodium is associated with reductions in UACR — particularly in sodium-sensitive individuals. The effect is amplified in the context of hypertension and diabetes, where sodium restriction is a documented component of kidney-protective management.

Transient causes: fever, exercise, dehydration

Albuminuria is not always persistent or pathological. Strenuous exercise, fever, dehydration, and urinary tract infections can produce transient increases in urinary albumin that resolve without intervention. For this reason, a single elevated UACR should generally be confirmed with a repeat measurement before drawing clinical conclusions. The standard clinical approach is to confirm albuminuria with two or three measurements over a three-to-six-month period before characterizing it as persistent.

Chronic kidney disease

In established chronic kidney disease (CKD), albuminuria reflects the degree of glomerular damage and is used alongside estimated GFR (eGFR) to classify disease stage and prognosis. Higher albuminuria in CKD is associated with faster progression to kidney failure. Monitoring both UACR and serum albumin provides complementary information: urinary albumin reflects kidney filtration integrity, while serum albumin reflects overall protein status and nutrition.

Which Biomarkers Are Relevant to Kidney Filtration Health?

• Urine albumin-to-creatinine ratio (UACR) — Quantifies albumin in urine, normalized for urine concentration; the primary albuminuria measure, ordered through a provider as a urine test
• Serum creatinine / eGFR — Kidney filtration rate; used alongside UACR to stage CKD
• HbA1c — Average blood sugar over ~3 months; key for assessing diabetic kidney risk
• Fasting glucose — Blood glucose status; elevated levels are directly nephrotoxic
• Fasting insulin — Insulin resistance indicator; relevant to metabolic contributions to albuminuria
• Serum albumin — Nutritional and liver synthetic function; low levels may accompany significant proteinuria
• hs-CRP — Inflammation; systemic inflammation contributes to glomerular damage

Superpower's Baseline Blood Panel includes creatinine, eGFR, albumin, glucose, HbA1c, and insulin — providing the core metabolic and kidney function context relevant to interpreting albuminuria.

Factors Associated with Lower Albuminuria

Because albuminuria reflects an underlying process, the most effective path to lower urinary albumin involves addressing its causes rather than treating the urinary finding directly. The following factors are consistently associated with reduced albuminuria in clinical research:

• Blood pressure management: Achieving and maintaining blood pressure within target ranges established with a provider is the most robustly supported intervention for reducing albuminuria in hypertensive individuals. Renin-angiotensin system (RAS) blockade with ACE inhibitors or ARBs has demonstrated kidney-protective effects beyond blood pressure reduction alone, though medication decisions are made by providers based on individual clinical context.
• Blood glucose control: In individuals with diabetes or insulin resistance, improving glycemic control is associated with reduced albuminuria and slower CKD progression. SGLT2 inhibitors, a class of diabetes medications, have demonstrated kidney-protective effects including albuminuria reduction in multiple large randomized trials — these are provider-prescribed medications.
• Dietary sodium reduction: Reducing sodium intake to levels consistent with DASH dietary guidance (generally below 2,300 mg/day, with lower targets for hypertensive individuals) is associated with lower blood pressure and reduced intraglomerular pressure, supporting lower albuminuria over time.
• Protein intake calibration: Extremely high protein intake may increase glomerular filtration pressure in individuals with existing kidney disease. Dietary protein recommendations in CKD are individualized by a provider or renal dietitian and depend on disease stage.
• Body weight: Adiposity is independently associated with intraglomerular hypertension and albuminuria. Weight loss in overweight and obese individuals is associated with reductions in UACR in multiple studies.